Quest Medical Inc. products

The Quest MPS System coordinated drug delivery technology is well known for eliminating patient dilution and the associated sequela caused by cardioplegia delivery. This technology has been proven beneficial for improved patient outcomes as well as a sound investment for hospitals.

Technology so unique, Quest Medical was awarded eight U.S. patents for this perfusion system. At the heart of the MPS®2 system are Spline-Piston pumps coupled with state-of-the-art pressure sensors enabling unparalleled drug delivery accuracy. The Quest MPS 2 System provides independent control of potassium and carioprotective drugs, providing the flexibility to deliver any cardioplegia protocol or strategy.

For many surgeons, the aortic punch is the perfect anastomotic device. Quest Medical offers surgeons a wide variety of aortic punches, including a unique aortotomy system that is ideal for creation of uniform openings at the aortotomy site for vein grafts, it’s called the PerfectCut. The PerfectCut system is designed to create a precise, consistent, reliable, repeatable incision and circular hole that eliminates lateral side notches from the aortotomy. The PerfectCut and CleanCut® punches produce uniform openings at the anastomotic site using a rotating, self-aligning cutter mechanism and cutting action, therefore requiring less force.

Quest Medical, Inc. revolutionizes split septum technology with enhanced safety features that assist in reducing infection control rates. The Q2® needleless connector’s straight unobstructed fluid path provides high flow rates and is engineered to suppress thrombotic occlusion risks caused by disconnecting syringes and other sets. Q2 needleless connectors enable multiple activations and maintain a sterile, closed system for increased patient safety and improved outcomes.

Quest’s manifold sets focus on safe and accurate infusion therapy delivery with minimal priming volumes and high flow rates. Our newest manifold, the ExoFlex, was designed to assist with reducing infection risks by developing a manifold that could be rigid or flexible in seconds – preventing a break in the line in between departments. Our full product line includes various tubing sizes, rigid and flexible variations, and component options to ensure your patients are kept safe.

Quest’s extension sets focus on safe and accurate infusion therapy delivery with minimal priming volumes and high flow rates. Our offerings include various tubing sizes and component options to ensure your patients are kept safe. Infection reduction was an inspiration in the development our new ExoFlex line, intended to address the needs of multiple departments while preventing a break in the line.

Quest’s IV administration sets focus on safe and accurate infusion therapy delivery by incorporating the use of split septum technology with check valves to prevent retrograde flow. Our variety of offerings are engineered to meet the demands of various departments in your facility including Anesthesia, Oncology and Critical Care.

Quest’s LacriCATH balloon catheters have revolutionized the treatment of blocked tear ducts (chronic epiphora and nasolacrimal duct obstruction) in children and adults.